| Authors: |
Morand EF; School of Clinical Sciences, Monash University, Melbourne, VIC, Australia., Furie R; Zucker School of Medicine at Hofstra/Northwell, Great Neck, NY, USA., Aringer M; Department of Medicine III, University Medical Center and Faculty of Medicine, TU Dresden, Dresden, Germany., Arnaud L; Department of Rheumatology, University Hospitals of Strasbourg and French National Reference Center for Rare Autoimmune Diseases (RESO), INSERM UMR-S 1109, Strasbourg, France., Peschken C; Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada., Hoi A; School of Clinical Sciences, Monash University, Melbourne, VIC, Australia., Lee KW; GMAP, AstraZeneca, Cambridge, UK., Hedberg J; BioPharmaceuticals Medical, AstraZeneca, Gothenburg, Sweden., Grünfeld Eén T; BioPharmaceuticals Medical, AstraZeneca, Gothenburg, Sweden., Tummala R; BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA., Chen S; BioPharmaceuticals Medical, AstraZeneca, Gaithersburg, MD, USA., Ding B; BioPharmaceuticals Medical, AstraZeneca, Gothenburg, Sweden. |
